Efficacy and safety of neratinib and capecitabine in HER2 positive metastatic breast cancer: a systematic review

被引：0
|
作者：
Mokalu, E. Wilhelmina [1 ]
Sabran, M. Zuhriansyah [1 ]
Yossy, P. [1 ]
Rubismo, K. Yogasvara [1 ]
Zebua, A. [1 ]
Albert, N. [1 ]
Hasan, J. Irisha Xenia [1 ]
Kurniawan, A. [2 ]
机构：
[1] Univ Pelita Harapan, Fac Med, Tangerang, Indonesia
[2] Univ Pelita Harapan, Dept Internal Med, Fac Med, Tangerang, Indonesia
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P90-6
引用
收藏
页码：S1393 / S1393
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of neratinib in patients with HER 2 breast cancer: a systematic review
    Christianto, P.
    Kurniawan, A.
    Suhardi, R.
    Atmaja, W. S.
    Chan, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1393 - S1393
  • [2] The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer
    Chila, Giovanna
    Guarini, Vincenzo
    Galizia, Danilo
    Geuna, Elena
    Montemurro, Filippo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2711 - 2720
  • [3] Tolerability of neratinib in older adults with HER2 positive or HER2 mutated metastatic breast cancer.
    Lee, Jin Sun
    Yost, Susan Elaine
    Stiller, Tracey
    Blanchard, Suzette
    Padam, Simran
    Katheria, Vani
    Tang, Aileen
    Martinez, Norma
    Patel, Niki Himat
    Sedrak, Mina S.
    Waisman, James Ross
    Li, Daneng
    Sanani, Shamel
    Presant, Cary A.
    Mortimer, Joanne E.
    Yuan, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
    Ma, Cynthia X.
    Bose, Ron
    Gao, Feng
    Freedman, Rachel A.
    Telli, Melinda L.
    Kimmick, Gretchen
    Winer, Eric
    Naughton, Michael
    Goetz, Matthew P.
    Russell, Christy
    Tripathy, Debu
    Cobleigh, Melody
    Forero, Andres
    Pluard, Timothy J.
    Anders, Carey
    Niravath, Polly Ann
    Thomas, Shana
    Anderson, Jill
    Bumb, Caroline
    Banks, Kimberly C.
    Lanman, Richard B.
    Bryce, Richard
    Lalani, Alshad S.
    Pfeifer, John
    Hayes, Daniel F.
    Pegram, Mark
    Blackwell, Kimberly
    Bedard, Philippe L.
    Al-Kateb, Hussam
    Ellis, Matthew J. C.
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5687 - 5695
  • [5] Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations
    Kourie, Hampig Raphael
    Chaix, Marie
    Gombos, Andrea
    Aftimos, Phillippe
    Awada, Ahmad
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (08) : 947 - 957
  • [6] Safety and Efficacy of Neratinib in Combination with Capecitabine in Patients with ErbB2-Positive Breast Cancer
    Saura, C.
    Garcia-Saenz, J. A.
    Xu, B.
    Harb, W.
    Moroose, R.
    Pluard, T.
    Kiger, C.
    Germa, C.
    Wang, K.
    Kim, S-B
    CANCER RESEARCH, 2011, 71
  • [7] Efficacy and safety of pertuzumab for HER2 positive metastatic breast cancer: a single institution experience
    Hara, Fumikata
    Aogi, Kenjiro
    Takashima, Seiki
    ANNALS OF ONCOLOGY, 2015, 26 : 141 - 141
  • [8] Lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer: A systematic review
    Madden, Rebecca
    Kosari, Sam
    Peterson, Gregory M.
    Bagheri, Nasser
    Thomas, Jackson
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (02) : 72 - 80
  • [9] Safety and Efficacy of Neratinib in Combination With Capecitabine in Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Saura, Cristina
    Garcia-Saenz, Jose A.
    Xu, Binghe
    Harb, Wael
    Moroose, Rebecca
    Pluard, Timothy
    Cortes, Javier
    Kiger, Corinne
    Germa, Caroline
    Wang, Kongming
    Martin, Miguel
    Baselga, Jose
    Kim, Sung-Bae
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (32) : 3626 - +
  • [10] Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancer
    Oliveira, Mafalda
    Garrigos, Laia
    Assaf, Juan David
    Escriva-de-Romani, Santiago
    Saura, Cristina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (09) : 731 - 741
12345